Skip to main contentSkip to navigation
Sirius Investors

PHIL.MI Stock: Philogen S.p.A. Stock Price, Analysis & Insights

Get live PHIL.MI stock price $22.65, comprehensive Philogen S.p.A. stock analysis, charts, news, and expert forecast. Real-time PHIL.MI stock data and investment insights.

22.65
0.44%Today
PHIL.MIPhilogen S.p.A. • Italian Stock Exchange • Healthcare
Market Cap
654.13M
Volume
11.57K
52W High
27.60
52W Low
19.56

Loading chart data...

Philogen S.p.A. (PHIL.MI) Overview

Philogen S.p.A. (PHIL.MI) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, PHIL.MI trades at $22.65 with a market capitalization of 654.13M . Over the past 52 weeks, PHIL.MI has traded between $19.56 and $27.60 , with the current price positioned at approximately 38% of this range . The stock currently tra...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 654.13M
  • Current price: $22.65
  • 52-week range: $19.56 - $27.60
  • P/E ratio: 3.97

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Philogen S.p.A. is a biotechnology firm dedicated to creating therapeutic agents for cancer and persistent inflammatory conditions. Among its pipeline, Nidlegy is being developed as an intralesional therapy for localized melanoma and non-melanoma ski...

Company Information

CEO
Dario Neri
Sector
Healthcare
Industry
Biotechnology
Employees
174

Contact Information

Address
Via Bellaria, 35
Country
IT

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 4.0)

Lower volatility stock (Beta: -0.00) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Philogen S.p.A. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Philogen S.p.A.
  • Investors should consider how Philogen S.p.A. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

654.13M

P/E Ratio (TTM)

3.97

Beta

-0.00

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

43/100 ⭐⭐⭐

Overall
-1.0%
NYSE
-1.6%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+0.4%+1.3%+2.0%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.